Abstract
Even though aging is the main risk factor for cancer, the age of a patient is still not generally accounted for in cancer research and clinical trials. We found that an aging-induced substance in the blood promotes cancer aggressiveness, revealing that age is an important factor to consider when developing personalized anti-cancer therapies. - submission by Ana P. Gomes
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
